A proud legacy of success with
a strong global focus

ニュースリリースへ

BioReliance announced today that it is expanding its Genetic Toxicology operations by adding two experienced scientists in this area. This expansion includes the additions of Dr. Leon F. Stankowski, Jr. and Dr. Shambhu Roy.

ダウンロード(PDF)

ROCKVILLE, MD – March 3, 2011 --

BioReliance announced today that it is expanding its Genetic Toxicology operations by adding two
experienced scientists in this area. This expansion includes the additions of Dr. Leon F. Stankowski, Jr.
and Dr. Shambhu Roy.

BioReliance Corporation is a leading contract services company in the area of product safety. Its clients
include pharmaceutical, biotechnology, chemical, consumer product, medical device and academic
organizations.

Dr. Stankowski joins BioReliance as a Principal Scientist and Program Consultant for Genetic
Toxicology. Dr. Stankowski received his PhD in Biomedical Sciences (Genetics) from the University of
Tennessee-Oak Ridge. Since 1984 he has worked in the field of Genetic Toxicology for both
Pharmaceutical and contract services companies and is globally recognized in the field. He will serve
BioReliance as both a study director and as principal scientific support for clients requiring advice on
program design.

Dr. Roy has been named Senior Scientist in the Genetic Toxicology Department. Dr. Roy will serve as
study director and have overall scientific oversight of the In Vitro Cytogenetics laboratory of the
Toxicology division. Dr. Roy has over 20 years experience in Genetic Toxicology and received his PhD
from Gujarat University in Ahmedabad, India. Dr. Roy was a post-doctoral research fellow with Dr.
David Eastmond (UC Riverside), and has spent his career in contract service organizations.
“I am delighted that these talented scientists are able to join our team at BioReliance,” said President and
CEO, Charles C. Harwood, Jr. “The additions of Dr. Stankowski and Dr. Roy, along with the recent
addition of Dr. Marilyn Aardema as Chief Scientific Officer for Toxicology, will serve to ensure that
BioReliance moves forward as the leader in the field of Genetic Toxicology.”


About BioReliance

BioReliance Corporation is a leading provider of cost-effective contract services, offering more than 1,000
tests or services related to biologics safety testing, specialized toxicology and animal health diagnostics.
Founded in 1947, BioReliance is headquartered in Rockville, Maryland, with laboratory operations in Rockville
and Scotland and offices in Tokyo, Japan, and Bangalore, India. The Company employs more than 600 people
globally. For more information, visit http://www.bioreliance.com/.